Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicinal composition for resisting fatigue as well as preparation method and application of medicinal composition

A composition and anti-fatigue technology, applied in the direction of drug combination, pharmaceutical formula, anti-toxin, etc., can solve the problems of drug shortage and unsatisfactory effect

Active Publication Date: 2018-03-06
JIANGSU KANION PHARMA CO LTD +1
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] The technical problem to be solved by the present invention is to provide a kind of anti-fatigue pharmaceutical composition to overcome defects such as lack of medicine for treating fatigue syndrome in the prior art, and the effect is not ideal.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicinal composition for resisting fatigue as well as preparation method and application of medicinal composition

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0071] Embodiment 1: the preparation of a kind of anti-fatigue pharmaceutical composition

[0072] Add 80g of crushed and sieved Epimedium, 50g of Rhodiola, 40g of Ginkgo biloba, and 30g of Cistanche into 1.6L of water to decoct and extract once, for 0.5 hours each time, filter, combine the filtrates, and concentrate under reduced pressure to obtain the relative density The extract is 1.1; the obtained extract is dried under reduced pressure and vacuum at a temperature of 40°C to obtain a dry extract, which is crushed through a 80-mesh sieve to obtain an anti-fatigue pharmaceutical composition.

Embodiment 2

[0073] Embodiment 2: the preparation of a kind of anti-fatigue pharmaceutical composition

[0074] Add 80g of crushed and sieved Epimedium, 50g of Rhodiola, 40g of Ginkgo biloba, and 30g of Cistanche into 2.0L of water to decoct and extract twice, each time for 1.5 hours, filter, combine the filtrates, and concentrate under reduced pressure to obtain a relative density The extract is 1.3; the obtained extract is vacuum-dried under reduced pressure at a temperature of 70°C to obtain a dry extract, which is crushed through a 90-mesh sieve to obtain an anti-fatigue pharmaceutical composition.

Embodiment 3

[0075] Embodiment 3: the preparation of a kind of anti-fatigue pharmaceutical composition

[0076] Add 80g of crushed and sieved Epimedium, 50g of Rhodiola, 40g of Ginkgo biloba, and 30g of Cistanche into 2.4L of water to decoct and extract 3 times, each time for 2 hours, filter, combine the filtrates, and concentrate under reduced pressure to obtain the relative density The extracted extract is 1.5; the obtained extract is vacuum-dried under reduced pressure at a temperature of 100°C to obtain a dry extract, which is crushed through a 100-mesh sieve to obtain an anti-fatigue pharmaceutical composition.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicinal composition for resisting fatigue as well as a preparation method and application of the medicinal composition. The composition is prepared from herba epimedii, rhodiola, folium ginkgo and cistanche deserticola. The specific preparation technology of the medicinal composition comprises the following steps: combining raw materials of a fatigue-resisting medicine,crushing and sieving; and then adding a solvent, decocting, filtering and carrying out vacuum concentration to obtain sugarless paste, and drying to obtain fatigue-resisting effective components. According to the medicinal composition for resisting the fatigue, disclosed by the invention, the fatigue-resisting effective components can be extracted from the medicinal composition for resisting thefatigue to the maximum extent; proved by a pharmacological test, the medicinal composition for resisting the fatigue has a fatigue-resisting effect, and can be used for improving body immunity, improving metabolic level of the body and enhancing the endurance of the body during overload.

Description

technical field [0001] The invention belongs to the field of traditional Chinese medicine pharmacy, and relates to an anti-fatigue pharmaceutical composition, a preparation method and application thereof. Background technique [0002] Fatigue syndrome (Chronic Fatigue Syndrome, CFS) is a group of persistent or recurrent fatigue, accompanied by a variety of neurological and psychiatric symptoms, but without organic and psychiatric diseases. Symptoms include fever, sore throat, swollen lymph nodes, extreme fatigue, loss of appetite, recurrent upper respiratory infections, small bowel discomfort, jaundice, anxiety, depression, irritability and mood swings, sleep disruption, sensitivity to light and heat, temporary Memory loss, inability to concentrate, headaches, cramps, muscle and joint pains. These symptoms are similar to colds and other viral infections, so it is easy to misjudge them. With the progress of society and the rapid development of science and technology, people...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/64A61P39/00
CPCA61K36/16A61K36/296A61K36/41A61K36/64A61K2300/00
Inventor 萧伟杨晶周习王宇婷李英丁岗王振中
Owner JIANGSU KANION PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products